Use the tirzepatide conversion chart to verify your numbers before starting any new protocol
Zhou M, Aziz M, Ochani M, Wang P
While the study had a large sample size and underwent manual review by experienced neuro-ophthalmologists, additional research, such as larger multicenter studies or prospective clinical trials, is required to confirm findings and explore causality
What happens after potential approval Assuming retatrutide eventually receives FDA approval, several practical questions arise for the research and clinical communities
This study has limitations, including a small number of participants and its nature as a retrospective analysis of existing medical records without a comparison group
GI side effects are uniformly higher with retatrutide, reflecting the additional receptor stimulation